Literature DB >> 23196975

Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.

Kenichi Nakajima1, Yasuchika Takeishi, Shinro Matsuo, Yoshimitsu Yamasaki, Tsunehiko Nishimura.   

Abstract

PURPOSE: Patients with metabolic syndrome (MetS) have potentially higher risk for cardiovascular events. The aim of this study was to evaluate the effect of MetS on cardiac events in type-2 diabetic patients asymptomatic for coronary artery disease (CAD) in a Japanese population.
METHODS: A total of 485 patients from a J-ACCESS-2 investigation with stress-gated myocardial perfusion imaging (MPI) and quantitative-gated MPI analysis were examined. Cardiovascular hard events (cardiac death and acute coronary syndrome) and total events during a 3-year follow-up were analyzed.
RESULTS: The MetS group (n = 229) had higher incidence of hypertension, dyslipidemia, and ventricular dilatation than the non-MetS group (n = 256). The hard events were 8 and 12 for the MetS and non-MetS groups (P = n.s.), and total events were 31 and 31 for each of these groups, respectively (P = n.s.). Significant variables related to total cardiovascular events included age, current smoking, insulin use, total cholesterol, ejection fraction, summed stress score ≥ 9, and summed difference score ≥ 2. Cox proportional hazard analysis and Kaplan-Meier survival analysis showed that only the summed stress score was related to total events (P = .01), and the presence and the number of items for MetS criteria were not.
CONCLUSION: In patients with type 2 diabetes asymptomatic for CAD, cardiovascular events and ischemia are as common in diabetic patients without MetS as in those with MetS. A high MPI defect score is related to total events including cardiac and cerebrovascular events.

Entities:  

Mesh:

Year:  2012        PMID: 23196975     DOI: 10.1007/s12350-012-9656-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  18 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Energy intake and obesity in Japanese patients with type 2 diabetes.

Authors:  Hirohito Sone; Yukio Yoshimura; Hideki Ito; Yasuo Ohashi; Nobuhiro Yamada
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

3.  Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease.

Authors:  Kenichi Nakajima; Shinro Matsuo; Chio Okuyama; Tsuguru Hatta; Kazumasa Tsukamoto; Shigeyuki Nishimura; Akira Yamashina; Hideo Kusuoka; Tsunehiko Nishimura
Journal:  Circ J       Date:  2011-11-19       Impact factor: 2.993

4.  Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study.

Authors:  Toshiharu Ninomiya; Yutaka Kiyohara; Michiaki Kubo; Koji Yonemoto; Yumihiro Tanizaki; Yasufumi Doi; Hideki Hirakata; Mitsuo Iida
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

5.  Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.

Authors:  Hirohito Sone; Sachiko Mizuno; Hitomi Fujii; Yukio Yoshimura; Yoshimitsu Yamasaki; Shun Ishibashi; Shigehiro Katayama; Yasushi Saito; Hideki Ito; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

6.  Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging.

Authors:  Kenichi Nakajima; Yoshimitsu Yamasaki; Hideo Kusuoka; Tohru Izumi; Atsunori Kashiwagi; Ryuzo Kawamori; Kazuaki Shimamoto; Nobuhiro Yamada; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

7.  Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study.

Authors:  Tsunehiko Nishimura; Kenichi Nakajima; Hideo Kusuoka; Akira Yamashina; Shigeyuki Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-10       Impact factor: 9.236

8.  Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.

Authors:  Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Hisatomi Arima; Michiaki Kubo; Yumihiro Tanizaki; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

9.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

10.  Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.

Authors:  Toshiharu Ninomiya; Michiaki Kubo; Yasufumi Doi; Koji Yonemoto; Yumihiro Tanizaki; Mahbubur Rahman; Hisatomi Arima; Kazuhiko Tsuryuya; Mitsuo Iida; Yutaka Kiyohara
Journal:  Stroke       Date:  2007-05-24       Impact factor: 7.914

View more
  3 in total

Review 1.  Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.

Authors:  Keiichiro Yoshinaga; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-04-22       Impact factor: 5.952

Review 2.  Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.

Authors:  Jun Watanabe; Kazuhiko Kotani
Journal:  Vasc Health Risk Manag       Date:  2020-04-17

3.  Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study.

Authors:  Zhiyong Xie; Zhilian Li; Wei Dong; Yuanhan Chen; Ruizhao Li; Yanhua Wu; Ting Lin; Yiming Tao; Huaban Liang; Wenjian Wang; Shuangxin Liu; Zhiming Ye; Wei Shi; Xinling Liang
Journal:  Clin Cardiol       Date:  2020-05-29       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.